Mammalian Cell Culture Medium Market - Forecast(2024 - 2030)

Report Code: HCR 1467 Report Format: PDF + Excel

Mammalian Cell Culture Medium Market Overview

Mammalian Cell Culture Medium Market size is projected to reach $3,310 million by 2026, growing at a CAGR of 11.8% over 2021-2026. Cell Culture is defined as the healthy growth of substance in order to increase the growth and survival of cell culture. Sometimes, mammalian cell culture need specialized media that serve the complex biology of eukaryotic cell lines and primary cells. Various components such as vitamins, amino acids, glucose, minerals, and supplements are needed for the healthy growth of mammalian cells. The cell culture media also support to control the pH and osmolarity of the cultured cells. The rising demand of 3D cell culture, increasing prevalence of influenza and growing development in technology for production of vaccine are the major factors driving the growth of this market. Furthermore, increasing research and development activities is set to further enhance the overall market demand for Mammalian Cell Culture Medium Market for the period 2021-2026.

Report Coverage

The report: “Mammalian Cell Culture Medium Market Forecast (2021-2026)”, by IndustryARC, covers an in-depth analysis of the following segments of the Mammalian Cell Culture Medium Market.

By Type: Classical Media, Stem Cell Media, Specialty Media, Serum-Free Media, and Others
By End-Use Industry: Biopharmaceutical, Academic & Research Institutes, and Others
By Geography: North America (U.S., Canada, Mexico), Europe (U.K, Germany, Italy, France, Spain, Russia, Rest of Europe), Asia Pacific (China, Australia, Japan, South Korea, India, Rest of Asia Pacific), South America (Brazil, Argentina, Others) and Rest of the World (Middle East, Africa)

Key Takeaways

  • Geographically, in 2020, North America dominated the Mammalian Cell Culture Medium Market owing to the increasing research and development activities, growing advancement in technology in the field of cell culture media and rising investments in order to innovative technologies and advances in cell culture applications.
  • Rising demand of 3D cell culture, increasing prevalence of influenza and growing development in technology for production of vaccine are likely to aid in the market growth of the Mammalian Cell Culture Medium. 
  • Detailed analysis of the Strength, Weakness, and Opportunities of the prominent manufacturers operating in the market will be provided in the Mammalian Cell Culture Medium Market report.
  • High cost associated with cell biology research is set to create hurdles for the Mammalian Cell Culture Medium Market.

Mammalian Cell Culture Medium Market Size, By End-Use Industry
2020-2026 (USD Million) 

Mammalian Cell Culture Medium Market

For more details on this report - Request for Sample

Mammalian Cell Culture Medium Segment Analysis – By Type

The Mammalian Cell Culture Medium Market based on Type can be further segmented into Classical Media, Stem Cell Media, Specialty Media, Serum-Free Media, and Others. The Classical Media segment is the major segment generating revenue in 2020. This is mainly owing to classical medium that are widely used for cell culture as it helps to support the growth of mammalian cells. Moreover, classical media are mostly used for the manufacturing of cell culture products and are increasing the growth of this market. The Serum-Free Media segment is estimated to register the fastest CAGR of 12.1% for the period 2021-2026. This is mainly owing to its consistent performance and also helps to reduce the contamination risk that increases the productivity and growth of this segment and are increasing the growth of this market. 

Mammalian Cell Culture Medium Segment Analysis – By End-Use Industry

The Mammalian Cell Culture Medium Market based on End-Use Industry can be further segmented into Biopharmaceutical, Academic & Research Institutes, and Others. The Biopharmaceutical segment registers for the highest Mammalian Cell Culture Medium Market share in 2020. This is mainly owing to increasing burden of infectious disease, rising demand of single use technologies. Moreover, rising approval by the regulatory agencies are increasing the growth of this segment. The Academic & Research Institutes segment is forecasted to register the fastest CAGR of 11.5% over 2021-2026. This is mainly owing to rising research and development activities in the field of cell culture that are increasing the growth of this market.

Mammalian Cell Culture Medium Segment Analysis – By Geography

North America dominated the Mammalian Cell Culture Medium Market with major share of 40% in 2020. This is owing to the increasing research and development activities, growing advancement in technology in the field of cell culture media and rising investments in order to innovative technologies and advances in cell culture applications. According to Pharmaceutical Research and Manufacturers Association, in 2019 about 79.6 billion are invested in biopharmaceutical industry for the research and development purposes in U.S. that are increasing the growth of this market.

However, Asia Pacific is estimated to be the significant growing market during the forecast period 2021-2026 owing to increasing number of cell culture technology.

Mammalian Cell Culture Medium Market Drivers 

Growing Prevalence of Influenza

Increasing prevalence of influenza diseases and rising awareness about the cell-culture based vaccines are increasing the growth of this market. According to Center for Disease Control and Prevention, more than 9 million people have influenza that increases the focus on developing various anti-infectives products that increases the demand of cell culture technology and are increasing the growth of the Mammalian Cell Culture Medium Market over 2021-2026.

Rising Development in Technology

Increasing advancement in technology for the development of proteomic gene expression and production of vaccine are increasing the growth of this Market. Moreover, rising research activities for cancer treatment and gene therapies are increasing the growth of Mammalian Cell Culture Medium Market over 2021-2026.

Covid-19 Impact: 

COVID-19 pandemic had greatly impacted the growth of Mammalian Cell Culture Medium Market. Currently, mammalian cell lines are used for research purposes for the treatment of SARS-CoV-2 virus. Cell culture medium helps to increase the nutrients in cells that helps to develop vaccine and are positively impacted the growth of this market.

Mammalian Cell Culture Medium Market Challenges 

High Cost Associated with Cell Biology Research

The factors that is set to impede the growth of the Mammalian Cell Culture Medium Market are the high investment cost for research in cell culture which is set to create hurdles for the Mammalian Cell Culture Medium Market.

Mammalian Cell Culture Medium Landscape

Product launches, acquisitions, collaboration, joint ventures, and geographical expansions are key strategies adopted by players in the Mammalian Cell Culture Medium Market. Mammalian Cell Culture Medium top 10 companies are Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Caisson Laboratories, Inc., Cell Culture Technologies LLC, Corning Incorporated, Fujifilm Holdings Corporation, GE Healthcare, HiMedia Laboratories Pvt., Ltd, Lonza Group Ltd, and Merck & Co., Inc.

Development

In May 2020, Chemovator GmbH launched a new product BIOFLOAT that are used for consumables in cell culture and are increasing the growth of this market.

Relevant Reports:

Report Code: HCR 0461

Report Code: HCR 0090

For more Lifesciences and Healthcare related reports, please click here
1. Mammalian Cell Culture Medium Market- Market Overview 
    1.1 Definitions and Scope 
2. Mammalian Cell Culture Medium Market - Executive Summary 
    2.1 Market Revenue, Market Size and Key Trends
    2.2 Key trends by Type 
    2.3 Key trends by Application 
    2.4 Key trends by End user 
    2.5 Key trends by Geography 
3. Mammalian Cell Culture Medium Market – Landscape 
    3.1 Comparative analysis 
        3.1.1 Market Share Analysis- Top Companies 
        3.1.2 Product Benchmarking- Top Companies 
        3.1.3 Top 5 Financials Analysis 
        3.1.4 Patent Analysis- Top Companies 
        3.1.5 Pricing Analysis 
4. Mammalian Cell Culture Medium Market - Startup companies Scenario Premium Premium 
    4.1 Top startup company Analysis by 
        4.1.1 Investment 
        4.1.2 Revenue 
        4.1.3 Market Shares 
        4.1.4 Market Size and Application Analysis 
        4.1.5 Venture Capital and Funding Scenario 
5. Mammalian Cell Culture Medium Market – Industry Market Entry Scenario Premium Premium 
    5.1 Regulatory Framework Overview 
    5.2 New Business and Ease of Doing business index 
    5.3 Successful venture profiles 
    5.4 Customer Analysis – Top companies 
6. Mammalian Cell Culture Medium Market - Market Forces 
    6.1 Market Drivers 
    6.2 Market Constraints 
    6.3 Market Opportunities 
    6.4 Porters five force model 
        6.4.1 Bargaining power of suppliers 
        6.4.2 Bargaining powers of customers 
        6.4.3 Threat of new entrants 
        6.4.4 Rivalry among existing players 
        6.4.5 Threat of substitutes  
7. Mammalian Cell Culture Medium Market – Strategic Analysis 
    7.1 Value Chain Analysis 
    7.2 Opportunity Analysis 
    7.3 Product Life Cycle 
    7.4 Supplier and Distributor  
8. Mammalian Cell Culture Medium Market – By Type (Market Size -$Million) 
    8.1 Natural Media 
        8.1.1 Biological fluids 
            8.1.1.1 Plasma 
            8.1.1.2 Serum 
            8.1.1.3 Amniotic Fluid 
            8.1.1.4 Others 
        8.1.2 Tissue Extracts 
            8.1.2.1 Spleen 
            8.1.2.2 Tumors 
            8.1.2.3 Others 
        8.1.3 Clots 
            8.1.3.1 Coagulants
    8.2 Artificial Media 
        8.2.1 Balanced Salt solutions 
            8.2.1.1 PBS 
            8.2.1.2 DPBS 
            8.2.1.3 HBSS 
            8.2.1.4 EBSS 
        8.2.2 Basal Media 
            8.2.2.1 MEM  
            8.2.2.2 DMEM 
        8.2.3 Complex Media 
            8.2.3.1 RPMI-1640 
            8.2.3.2 IMDM 
    8.3 Serum free Media 
    8.4 Stem Cell Media 
9. Mammalian Cell Culture Medium Market – By Application (Market Size -$Million) 
    9.1 Cancer Research 
    9.2 Tissue culture and Engineering 
    9.3 Gene Therapy 
    9.4 Drug Screening and development 
    9.5 Biopharmaceuticals  
    9.6 Others 
10. Mammalian Cell Culture Medium Market – By End user (Market Size -$Million) 
    10.1 Research Institutes 
    10.2 Bio technology companies 
    10.3 Pharmaceutical companies 
11. Mammalian Cell Culture Medium Market - By Geography (Market Size -$Million) 
    11.1 North America 
        11.1.1 U.S 
        11.1.2 Canada
        11.1.3 Mexico 
    11.2 South America 
        11.2.1 Brazil 
        11.2.2 Argentina 
        11.2.3 Colombia 
        11.2.4 Rest of South America 
    11.3 Europe 
        11.3.1 UK 
        11.3.2 Germany 
        11.3.3 France 
        11.3.4 Italy 
        11.3.5 Belgium 
        11.3.6 Rest of Europe 
    11.4 Asia-Pacific 
        11.4.1 China 
        11.4.2 Japan 
        11.4.3 India 
        11.4.4 Taiwan 
        11.4.5 South Korea 
        11.4.6 Australia and New Zeeland 
        11.4.7 Rest of APAC 
    11.5 Rest of the World 
        11.5.1 Middle East 
        11.5.2 Africa 
12. Mammalian Cell Culture Medium Market – Entropy 
    12.1 New Product Launches 
    12.2 M&As, Collaborations, JVs and Partnerships 
13. Mammalian Cell Culture Medium Market – Key Company List by Country Premium Premium 
14. Mammalian Cell Culture Medium Market Company Analysis (Market Share, Company Revenue, Products, M&A, Developments) 
    14.1 Corning 
    14.2 Thermo Fisher 
    14.3 Merck KGaA 
    14.4 Cytiva 
    14.5 Lonza 
    14.6 Takara 
    14.7 HiMedia 
    14.8 Sartorius AG 
    14.9 Stemcell Technologies 
    14.10 Miltenyi Biotec 
    14.11 CellGenix GmbH 
    14.12 PromoCell 
    14.13 Fujifilm 
    14.14 Shanghai OPM 
    14.15 CNBG 
    14.16 Ajinomoto Kohjin Bio 
    14.17 Ajnomoto Genexine 
    14.18 Becton Dickinson 
    14.19 BBI Solutions 
"*Financials would be provided on a best efforts basis for private companies"